| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |